Page 1 of Clinical Trials for Biological HIV-1 Immunogen, 70 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
Controlling Acute or Early HIV Infection With Antiretroviral Drugs, With or Without a Candidate Vaccine
Last Updated: May 28, 2008
Condition(s): HIV Infections
2
Completed
Phase I Study to Evaluate the Safety and Immunogenicity of HIV-1 Immunogen in Children With HIV-1 Infection
Last Updated: March 3, 2008
Condition(s): HIV Infection
3
Completed
A Multicenter, Double-Blind, Phase III, Adjuvant-Controlled Study of the Effect of 10 Units of HIV-1 Immunogen (Remune) Compared to Incomplete Freund's Adjuvant (IFA) Alone Every 12 Weeks on AIDS-Free Survival in Subjects With HIV Infection and CD4 T-Lymphocytes Between 300 and 549 Cells/microL Rega
Last Updated: June 23, 2005
Condition(s): HIV Infections
4
Completed
An Expanded Access Open Label Protocol of Remune (HIV-1 Immunogen) in HIV-1-Infected Adults With CD4 Count 550 Cells /Ml and Greater.
Last Updated: June 23, 2005
Condition(s): HIV Infections
5
Completed
Immune Responses in HIV-Positive Patients Receiving an Anti-HIV Drug Combination When Given the HIV Vaccines Remune and vCP1452
Last Updated: May 21, 2012
Condition(s): HIV Infections
6
Withdrawn
Effects of Immunization With HIV-1 Immunogen Plus Anti-HIV Treatment Interruption on the Levels of HIV
Last Updated: May 17, 2012
Condition(s): HIV Infections
7
Terminated
Effectiveness of Adding Remune to Your Current Anti-HIV Drug Combination
Last Updated: July 29, 2008
Condition(s): HIV Infections
8
Completed
A Study to Test If Giving Remune (an HIV Vaccine) Can Improve the Immune Systems of HIV-Positive Patients Who Are Also Participating in ACTG 328
Last Updated: May 16, 2012
Condition(s): HIV Infections
9
Completed
Effectiveness of Giving an HIV Vaccine (Remune) to HIV-Positive Patients Receiving an Anti-HIV Drug Combination
Last Updated: May 21, 2012
Condition(s): HIV Infections
10
Completed
An Expanded Access Open-Label, Compassionate Use Protocol of Remune in HIV-1-Infected Adults With CD4 Count Less Than 300 Cells/Ml
Last Updated: June 23, 2005
Condition(s): HIV Infections
11
Completed
Safety and Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine (Remune)
Last Updated: June 23, 2005
Condition(s): HIV Infections
12
Active, not recruiting
Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine (Remune)
Last Updated: June 23, 2005
Condition(s): HIV Infections
13
Completed
A Multicenter, Randomized, Placebo-Controlled, Double-Blinded, Phase I Trial to Evaluate the Safety and Immunogenicity of Live Recombinant Canarypox ALVAC-HIV vCP205 Combined With GM-CSF in Healthy, HIV-1 Uninfected Volunteers
Last Updated: May 16, 2012
Condition(s): HIV Infections
14
Completed
A Phase I Trial To Evaluate the Safety and Immunogenicity of the UBI HIV-1MN PND Peptide Immunogen, Given by IM Injection, in Combination With the UBI Microparticulate Monovalent HIV-1 MN Branched Peptide Given Orally, in HIV-1 Uninfected Volunteers.
Last Updated: June 23, 2005
Condition(s): HIV Infections
15
Completed
A Phase I Comparative Blinded Trial of Several HIV-1 Derived Immunogens in Infected Individuals With >= 500 CD4 Cells/mm3
Last Updated: May 23, 2012
Condition(s): HIV Infections
16
Completed
A Phase I Safety and Immunogenicity Trial of UBI Multivalent HIV-1 Peptide Immunogen in HIV-1 Seronegative Human Subjects
Last Updated: September 8, 2008
Condition(s): HIV Infections
17
Completed
Study of the HIV gp120/NefTat/AS02A Vaccine to Treat Individuals With Chronic HIV-1 Infection on Highly Active Antiretroviral Therapy (HAART)
Last Updated: February 12, 2010
Condition(s): HIV Infections
18
Completed
A Phase I Safety and Immunogenicity Trial of HIV-1 gp120 C4-V3 Hybrid Polyvalent Peptide Immunogen Mixed in Mineral Oil Containing Mannose Mono-Oleate (IFA)
Last Updated: May 10, 2012
Condition(s): HIV Infections
19
Completed
A Phase I Study to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Antigen in Children Born to HIV-Infected Mothers
Last Updated: May 22, 2012
Condition(s): HIV Infections; HIV Seronegativity
20
Completed
A Phase I/II Study of Delayed-Type Hypersensitivity (DTH) Reactions to Intradermal HIV Envelope Antigen
Last Updated: May 23, 2012
Condition(s): HIV Infections

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Biological+HIV-1+Immunogen

Page 1 of Clinical Trials for Biological HIV-1 Immunogen, 70 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About